TMO in the 13F filings
Thermo Fisher Scientific Inc · CUSIP 883556102
- Quarter end
- 30 Jun 2026
- the date the book describes
- Filed
- 27 Oct 2026
- latest of these filings; the earliest 31 Jul 2026
- Managers listing it
- 48
- at least, of 95 tracked, among listed positions
- Comparable managers
- 91
- filed both Q1 2026 and Q2 2026; 33 listed it in both
- Shares listed
- 51,755,013
- combined, among listed positions
- Reported value
- $26.7bn
- combined, at the quarter end
1 line marked †. Value as filed implies a price far from other filers'. Each counts in holders and value as filed, and is left out of the net change in shares.
AllianceBernstein LP. Values in this filing are at the previous quarter end's prices; its share count is the quarter end's.
Among the 91 comparable managers: 27 buyers (opened or added shares) and 22 sellers (trimmed or exited), at least, among listed positions. Their net change in shares was +3,868,383.
Managers listing TMO in Q2 2026
48 of 48 holders
Largest increases and reductions, by shares
Increases
- Fidelity (FMR LLC)existing position · 14,084,488 shares now+3,308,052
- Dodge & Coxexisting position · 3,054,778 shares now+3,029,037
- Glenview Capital Management LLCexisting position · 627,240 shares now+376,715
- Arrowstreet Capital LPexisting position · 1,007,394 shares now+373,025
- D. E. Shaw & Co.existing position · 641,637 shares now+338,789
Reductions
- T. Rowe Price Associates Incexisting position · 5,116,336 shares now-1,199,135
- Wellington Management Group LLPexisting position · 979,181 shares now-499,070
- Marshall Wace LLPexisting position · 4,321 shares now-472,929
- Capital World Investorsexisting position · 6,195,370 shares now-450,946
- AllianceBernstein LPexisting position · 1,849,037 shares now-341,571
New positions and exits
New (7)
Exited (1)
- Renaissance Technologies LLCwas $68m
Ownership over time
Tracked managers listing it, at least.
| Quarter | Holders | Reported value | Buyers | Sellers |
|---|---|---|---|---|
| Q2 2013 | 19 | $8.8bn | n.a. | n.a. |
| Q3 2013 | 19 | $10.1bn | n.a. | n.a. |
| Q4 2013 | 19 | $12.6bn | n.a. | n.a. |
| Q1 2014 | 22 | $12.8bn | n.a. | n.a. |
| Q2 2014 | 22 | $12.9bn | n.a. | n.a. |
| Q3 2014 | 22 | $13.6bn | n.a. | n.a. |
| Q4 2014 | 30 | $14.7bn | n.a. | n.a. |
| Q1 2015 | 27 | $15.0bn | n.a. | n.a. |
| Q2 2015 | 27 | $14.1bn | n.a. | n.a. |
| Q3 2015 | 20 | $13.5bn | n.a. | n.a. |
| Q4 2015 | 21 | $15.4bn | n.a. | n.a. |
| Q1 2016 | 21 | $14.7bn | n.a. | n.a. |
| Q2 2016 | 20 | $14.9bn | n.a. | n.a. |
| Q3 2016 | 18 | $15.7bn | n.a. | n.a. |
| Q4 2016 | 31 | $13.2bn | n.a. | n.a. |
| Q1 2017 | 27 | $13.8bn | n.a. | n.a. |
| Q2 2017 | 29 | $15.7bn | n.a. | n.a. |
| Q3 2017 | 28 | $17.9bn | n.a. | n.a. |
| Q4 2017 | 20 | $18.2bn | n.a. | n.a. |
| Q1 2018 | 28 | $20.1bn | n.a. | n.a. |
| Q2 2018 | 27 | $19.9bn | n.a. | n.a. |
| Q3 2018 | 27 | $23.6bn | n.a. | n.a. |
| Q4 2018 | 30 | $21.6bn | n.a. | n.a. |
| Q1 2019 | 30 | $27.4bn | n.a. | n.a. |
| Q2 2019 | 33 | $28.8bn | n.a. | n.a. |
| Q3 2019 | 26 | $27.9bn | n.a. | n.a. |
| Q4 2019 | 26 | $30.3bn | n.a. | n.a. |
| Q1 2020 | 27 | $25.8bn | n.a. | n.a. |
| Q2 2020 | 29 | $32.6bn | n.a. | n.a. |
| Q3 2020 | 29 | $38.9bn | n.a. | n.a. |
| Q4 2020 | 33 | $39.2bn | n.a. | n.a. |
| Q1 2021 | 35 | $36.5bn | n.a. | n.a. |
| Q2 2021 | 33 | $38.3bn | n.a. | n.a. |
| Q3 2021 | 32 | $42.6bn | n.a. | n.a. |
| Q4 2021 | 38 | $50.1bn | n.a. | n.a. |
| Q1 2022 | 32 | $43.2bn | n.a. | n.a. |
| Q2 2022 | 33 | $38.9bn | n.a. | n.a. |
| Q3 2022 | 26 | $34.3bn | n.a. | n.a. |
| Q4 2022 | 29 | $37.0bn | n.a. | n.a. |
| Q1 2023 | 35 | $37.1bn | n.a. | n.a. |
| Q2 2023 | 39 | $33.5bn | n.a. | n.a. |
| Q3 2023 | 39 | $32.6bn | n.a. | n.a. |
| Q4 2023 | 41 | $32.7bn | 19 | 23 |
| Q1 2024 | 30 | $34.1bn | 14 | 18 |
| Q2 2024 | 38 | $30.6bn | 25 | 18 |
| Q3 2024 | 30 | $33.8bn | 12 | 19 |
| Q4 2024 | 36 | $27.6bn | 22 | 15 |
| Q1 2025 | 31 | $24.2bn | 12 | 22 |
| Q2 2025 | 39 | $18.8bn | 27 | 11 |
| Q3 2025 | 32 | $21.9bn | 22 | 13 |
| Q4 2025 | 32 | $29.9bn | 27 | 20 |
| Q1 2026 | 34 | $24.4bn | 23 | 23 |
| Q2 2026 | 36 | $26.4bn | 27 | 22 |
Compare with…
Holders over time, buyers and sellers, and the managers holding both, side by side for up to four stocks.
TMO and LLY →TMO and JNJ →TMO and VRTX →Choose a stock to compare with TMO →
How much of the picture this is
A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. It shows no shorts, cash, bonds or performance, and it is never today’s portfolio. Large books are listed to their largest positions, so a manager missing from this table may still hold a small position below that line. These are 95 tracked managers, not the institutional market.
Which funds own TMO, latest filings →Back to the 13F Explorer →